Ethan Cottrill
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ethan Cottrill has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- William Richardson
Department of Orthopedic Surgery, Duke University, Durham, NC 27710, USA
2 shared publications - Alan H. Daniels
Brown University, Providence, USA
1 shared publication Alexander Perdomo-Pantoja
Departments of Neurosurgery
1 shared publication- Allen A. Champagne
Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA
1 shared publication - Amer Sebaaly
Hôtel-Dieu de France, Beirut, Lebanon
1 shared publication - Andrew William Froehle
Department of Orthopaedic Surgery, Wright State University Boonshoft School of Medicine, Dayton, USA
1 shared publication
Latest Publications
- Open Access
- 13 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 7895
Sacral Fractures Are Increasing in Frequency, with Females and Falls Comprising the Majority: A NEISS Cross-Sectional Study from 2003 to 2022
Background/Objectives: Sacral fractures are clinically important injuries that may be occult at presentation and may occur after both low-energy falls and higher-energy trauma. National emergency department data describing temporal trends, mechanisms, associated fractures, and disposition remain limited. Methods: A retrospective cross-sectional study was performed using the National Electronic Injury Surveillance System from 2003 to 2022. Sacral fracture emergency department visits were identified using diagnosis and body-part codes with narrative confirmation of sacral involvement. National estimates were generated using NEISS survey weights. The primary outcome was population-based ED visits per 100,000 United States population, overall and stratified by sex. Secondary outcomes included mechanism category, injury location, concurrent vertebral or hip fracture, and emergency department disposition. Results: A total of 1747 sacral fracture emergency department visits were identified, representing an estimated 72,215 national visits. Low-energy falls accounted for 67.9% of presentations. Mean age was 61.1 years, and 70.0% of patients were female. Injuries most commonly occurred at home (50.5%). Annual ED visit rate increased from 2003 to 2022, with a steeper rise among females than males. Disposition varied by mechanism. Motor vehicle or transport-related injuries had the highest admission or hospitalization proportion (54.6%), whereas high-energy falls had the highest treated-and-released proportion (62.0%). In survey-aware multinomial regression, increasing age was associated with lower odds of high-energy falls, motor vehicle or transport injuries, and non-fall other injuries compared with low-energy falls. Male sex was associated with motor vehicle or transport mechanism. Conclusions: National emergency department presentations for sacral fractures increased from 2003 to 2022 and were dominated by low-energy falls among older female patients. However, transport-related and higher-energy mechanisms showed distinct demographic and disposition patterns. These findings supported trauma-system awareness, mechanism-informed co-injury screening, and orthopedic or spine referral pathways for sacral fracture presentations.
- 13 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (20) , 7895
Open AccessSacral Fractures Are Increasing in Frequency, with Females and Falls Comprising the Majority: A NEISS Cross-Sectional Study from 2003 to 2022
Background/Objectives: Sacral fractures are clinically important injuries that may be occult at presentation and may occur after both low-energy falls and higher-energy trauma. National emergency department data describing temporal trends, mechanisms, associated fractures, and disposition remain limited. Methods: A retrospective cross-sectional study was performed using the National Electronic Injury Surveillance System from 2003 to 2022. Sacral fracture emergency department visits were identified using diagnosis and body-part codes with narrative confirmation of sacral involvement. National estimates were generated using NEISS survey weights. The primary outcome was population-based ED visits per 100,000 United States population, overall and stratified by sex. Secondary outcomes included mechanism category, injury location, concurrent vertebral or hip fracture, and emergency department disposition. Results: A total of 1747 sacral fracture emergency department visits were identified, representing an estimated 72,215 national visits. Low-energy falls accounted for 67.9% of presentations. Mean age was 61.1 years, and 70.0% of patients were female. Injuries most commonly occurred at home (50.5%). Annual ED visit rate increased from 2003 to 2022, with a steeper rise among females than males. Disposition varied by mechanism. Motor vehicle or transport-related injuries had the highest admission or hospitalization proportion (54.6%), whereas high-energy falls had the highest treated-and-released proportion (62.0%). In survey-aware multinomial regression, increasing age was associated with lower odds of high-energy falls, motor vehicle or transport injuries, and non-fall other injuries compared with low-energy falls. Male sex was associated with motor vehicle or transport mechanism. Conclusions: National emergency department presentations for sacral fractures increased from 2003 to 2022 and were dominated by low-energy falls among older female patients. However, transport-related and higher-energy mechanisms showed distinct demographic and disposition patterns. These findings supported trauma-system awareness, mechanism-informed co-injury screening, and orthopedic or spine referral pathways for sacral fracture presentations.
- 6 January 2026
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 36 (1) , 66
The impact of workers’ compensation claims on outcomes of cervical spine surgery: a meta-analysis
Study design Meta-analysis. Objective This meta-analysis aims to clarify the clinical and functional impact of Workers’ compensation (WC) status on cervical spine surgery outcomes. Background Work-related musculoskeletal disorders can lead to significant disability, impaired productivity, and quality of life. WC status in patients has been linked to worse outcomes following orthopedic surgeries, including cervical spine procedures (ACDF, CDA). Studies analyzing the influence of WC claims on different cervical spine surgeries report contradicting results. Methods Adhering to the PRISMA guidelines, Google Scholar, Cochrane, and PubMed were searched since inception until May 2025. The data that was extracted included overall complications, number of reoperations, surgery-related outcomes (estimated blood loss (EBL), operative time, and length of stay (LOS)), the improvement in patient reported outcome measures (PROMS) at 1 year post-operatively, number of patients returning to work, and mean time to return to work. Results Eight retrospective studies met the inclusion criteria, including 801 patients in the WC group and 1102 in the NWC group. The patients in the WC group had a shorter operative time (Mean difference = − 2.83 min; 95% CI − 5.03 to − 0.64, p = 0.01), and LOS (Mean difference = − 2.62 h; 95% CI − 4.61 to − 0.63, p = 0.01). On the other hand, they had a worse improvement in neck pain (Standardized mean difference = − 0.32; 95% CI − 0.45 to − 0.19, p < 0.001), and arm pain (Standardized mean difference = − 0.26; 95% CI − 0.39 to − 0.13, p < 0.001), as well as a longer time to return to work (Mean difference = 4.53 weeks; 95% CI 2.70–6.36, p < 0.001). Conclusion Patients with WC claims had worse improvement in arm and neck pain and needed more time to return to work. These results highlight the impact of WC claims have on cervical spine surgery outcomes, making compensation status an essential factor to consider in clinical evaluation and patient counseling.
- 6 January 2026
- Published by Springer Nature in European Journal of Orthopaedic Surgery & Traumatology
- Vol. 36 (1) , 66
The impact of workers’ compensation claims on outcomes of cervical spine surgery: a meta-analysis
Study design Meta-analysis. Objective This meta-analysis aims to clarify the clinical and functional impact of Workers’ compensation (WC) status on cervical spine surgery outcomes. Background Work-related musculoskeletal disorders can lead to significant disability, impaired productivity, and quality of life. WC status in patients has been linked to worse outcomes following orthopedic surgeries, including cervical spine procedures (ACDF, CDA). Studies analyzing the influence of WC claims on different cervical spine surgeries report contradicting results. Methods Adhering to the PRISMA guidelines, Google Scholar, Cochrane, and PubMed were searched since inception until May 2025. The data that was extracted included overall complications, number of reoperations, surgery-related outcomes (estimated blood loss (EBL), operative time, and length of stay (LOS)), the improvement in patient reported outcome measures (PROMS) at 1 year post-operatively, number of patients returning to work, and mean time to return to work. Results Eight retrospective studies met the inclusion criteria, including 801 patients in the WC group and 1102 in the NWC group. The patients in the WC group had a shorter operative time (Mean difference = − 2.83 min; 95% CI − 5.03 to − 0.64, p = 0.01), and LOS (Mean difference = − 2.62 h; 95% CI − 4.61 to − 0.63, p = 0.01). On the other hand, they had a worse improvement in neck pain (Standardized mean difference = − 0.32; 95% CI − 0.45 to − 0.19, p < 0.001), and arm pain (Standardized mean difference = − 0.26; 95% CI − 0.39 to − 0.13, p < 0.001), as well as a longer time to return to work (Mean difference = 4.53 weeks; 95% CI 2.70–6.36, p < 0.001). Conclusion Patients with WC claims had worse improvement in arm and neck pain and needed more time to return to work. These results highlight the impact of WC claims have on cervical spine surgery outcomes, making compensation status an essential factor to consider in clinical evaluation and patient counseling.
- Open Access
- 5 January 2025
- Published by Elsevier in World Neurosurgery
- Vol. 194, 123551
Synthesis and Preclinical Evaluation of a Novel Oxy133-Infused Biomimetic Bone Graft Using a Rat Model of Posterolateral Spinal Fusion
- 5 January 2025
- Published by Elsevier in World Neurosurgery
- Vol. 194, 123551
Open AccessSynthesis and Preclinical Evaluation of a Novel Oxy133-Infused Biomimetic Bone Graft Using a Rat Model of Posterolateral Spinal Fusion
- 5 April 2024
- Published by Elsevier in World Neurosurgery
- Vol. 186, 219-234.e4
Gene Therapy and Spinal Fusion: Systematic Review and Meta-Analysis of the Available Data
- 5 April 2024
- Published by Elsevier in World Neurosurgery
- Vol. 186, 219-234.e4
Gene Therapy and Spinal Fusion: Systematic Review and Meta-Analysis of the Available Data
- Open Access
- 1 July 2023
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 39 (1) , 113-121
Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion
OBJECTIVE: Infuse bone graft is a widely used osteoinductive adjuvant; however, the simple collagen sponge scaffold used in the implant has minimal inherent osteoinductive properties and poorly controls the delivery of the adsorbed recombinant human bone morphogenetic protein–2 (rhBMP-2). In this study, the authors sought to create a novel bone graft substitute material that overcomes the limitations of Infuse and compare the ability of this material with that of Infuse to facilitate union following spine surgery in a clinically translatable rat model of spinal fusion. METHODS: The authors created a polydopamine (PDA)–infused, porous, homogeneously dispersed solid mixture of extracellular matrix and calcium phosphates (BioMim-PDA) and then compared the efficacy of this material directly with Infuse in the setting of different concentrations of rhBMP-2 using a rat model of spinal fusion. Sixty male Sprague Dawley rats were randomly assigned to each of six equal groups: 1) collagen + 0.2 µg rhBMP-2/side, 2) BioMim-PDA + 0.2 µg rhBMP-2/side, 3) collagen + 2.0 µg rhBMP-2/side, 4) BioMim-PDA + 2.0 μg rhBMP-2/side, 5) collagen + 20 µg rhBMP-2/side, and 6) BioMim-PDA + 20 µg rhBMP-2/side. All animals underwent posterolateral intertransverse process fusion at L4–5 using the assigned bone graft. Animals were euthanized 8 weeks postoperatively, and their lumbar spines were analyzed via microcomputed tomography (µCT) and histology. Spinal fusion was defined as continuous bridging bone bilaterally across the fusion site evaluated via µCT. RESULTS: The fusion rate was 100% in all groups except group 1 (70%) and group 4 (90%). Use of BioMim-PDA with 0.2 µg rhBMP-2 led to significantly greater results for bone volume (BV), percentage BV, and trabecular number, as well as significantly smaller trabecular separation, compared with the use of the collagen sponge with 2.0 µg rhBMP-2. The same results were observed when the use of BioMim-PDA with 2.0 µg rhBMP-2 was compared with the use of the collagen sponge with 20 µg rhBMP-2. CONCLUSIONS: Implantation of rhBMP-2–adsorbed BioMim-PDA scaffolds resulted in BV and bone quality superior to that afforded by treatment with rhBMP-2 concentrations 10-fold higher implanted on a conventional collagen sponge. Using BioMim-PDA (vs a collagen sponge) for rhBMP-2 delivery could significantly lower the amount of rhBMP-2 required for successful bone grafting clinically, improving device safety and decreasing costs.
- 1 July 2023
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Spine
- Vol. 39 (1) , 113-121
Open AccessCreation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion
OBJECTIVE: Infuse bone graft is a widely used osteoinductive adjuvant; however, the simple collagen sponge scaffold used in the implant has minimal inherent osteoinductive properties and poorly controls the delivery of the adsorbed recombinant human bone morphogenetic protein–2 (rhBMP-2). In this study, the authors sought to create a novel bone graft substitute material that overcomes the limitations of Infuse and compare the ability of this material with that of Infuse to facilitate union following spine surgery in a clinically translatable rat model of spinal fusion. METHODS: The authors created a polydopamine (PDA)–infused, porous, homogeneously dispersed solid mixture of extracellular matrix and calcium phosphates (BioMim-PDA) and then compared the efficacy of this material directly with Infuse in the setting of different concentrations of rhBMP-2 using a rat model of spinal fusion. Sixty male Sprague Dawley rats were randomly assigned to each of six equal groups: 1) collagen + 0.2 µg rhBMP-2/side, 2) BioMim-PDA + 0.2 µg rhBMP-2/side, 3) collagen + 2.0 µg rhBMP-2/side, 4) BioMim-PDA + 2.0 μg rhBMP-2/side, 5) collagen + 20 µg rhBMP-2/side, and 6) BioMim-PDA + 20 µg rhBMP-2/side. All animals underwent posterolateral intertransverse process fusion at L4–5 using the assigned bone graft. Animals were euthanized 8 weeks postoperatively, and their lumbar spines were analyzed via microcomputed tomography (µCT) and histology. Spinal fusion was defined as continuous bridging bone bilaterally across the fusion site evaluated via µCT. RESULTS: The fusion rate was 100% in all groups except group 1 (70%) and group 4 (90%). Use of BioMim-PDA with 0.2 µg rhBMP-2 led to significantly greater results for bone volume (BV), percentage BV, and trabecular number, as well as significantly smaller trabecular separation, compared with the use of the collagen sponge with 2.0 µg rhBMP-2. The same results were observed when the use of BioMim-PDA with 2.0 µg rhBMP-2 was compared with the use of the collagen sponge with 20 µg rhBMP-2. CONCLUSIONS: Implantation of rhBMP-2–adsorbed BioMim-PDA scaffolds resulted in BV and bone quality superior to that afforded by treatment with rhBMP-2 concentrations 10-fold higher implanted on a conventional collagen sponge. Using BioMim-PDA (vs a collagen sponge) for rhBMP-2 delivery could significantly lower the amount of rhBMP-2 required for successful bone grafting clinically, improving device safety and decreasing costs.